Transdermal Medical Patch Market Share, Trends, and Analysis by 2028
Transdermal Medical Patch Market: Strategic Insights
Transdermal Medical Patch Market
-
CAGR (2022 - 2028)4.0% -
Market Size 2022
US$ 8.25 Billion -
Market Size 2028
US$ 10.8 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Prevalence of Chronic Diseases
- Growing Consumption of Tobacco
FUTURE TRENDS
- Advancements in Smart Patches and Three- Dimensional (3D)-Printed Patches
OPPORTUNITIES
- Increasing Strategic Initiatives
Key Players
- Hisamitsu Pharmaceutical Co Inc
- Medline Industries LP
- Johnson Johnson
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- UCB SA
- Viatris Inc
- Endo Pharmaceuticals Inc
- Boehringer Ingelheim International GmbH
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type - Single Layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Reservoir
- Vapor Patch
- Matrix
Application - Neurologic Conditions
- Pain Management
- Nicotine Cessation
- Cardiovascular Disorders
- Hormonal Therapy
Distribution Channel - Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Get Free Sample For